UHOIF yields 1.97% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, UHOIF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of UHOIF + JNJ for your $10,000?
Ushio Inc. produces and sells light application products, industrial equipment, and other products in Japan, rest of Asia, Europe, North America, and internationally. The company offers laser diodes, LED chips/packages, ultraviolet (UV) lamps, xenon lamps, halogen lamp heaters, and halogen heaters. It also provides lighting for general illumination, architecture and landscape, marine applications, and plant growth applications, as well as lamps for data projectors and LED lamps for illumination. In addition, the company offers light source units, excimer lamps and irradiation units, exposure units, illumination light sources, fishing lamps, and warning lights, as well as lighting for security applications and UV-LED for printing UniJet series. Further, it provides lithography tools and aligners, cleaning and modification systems, UV curing systems, measurement equipment, photoheating equipment, laboratory instruments, environment and sanitation related equipment, and imaging and illumination systems. Additionally, the company offers power supply repair services, power supplies, plastic injection-molding machines, mold protection devices, joints and tubing, plastic materials, factory automation products, sound-systems, and cinema servers. Ushio Inc. was incorporated in 1949 and is headquartered in Tokyo, Japan.
Full UHOIF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.